Skip to main content

Clinical trial AMC303-01

A safety, tolerability and pharmacokinetic dose escalation expansion, Phase I/Ib study of AMC303 as monotherapy in patients with advanced or metastatic, malignant solid tumour of epithelial origin

Cancers
Organ Multiples
Trial status Trial closed for recruitment
Investigator
Trial type
Interventionnal with IMP
Phase Trial phase 1/1b
Academic trial Non
Sponsor Amcure GmbH
EudraCT Identifier 2016-001358-16
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03009214
Inclusion criteria any line RECIST 1.1
Last update